Design Therapeutics, Inc. (DSGN) Total liabilities 2020–2025
Design Therapeutics, Inc. (DSGN) total liabilities at each fiscal year-end, per SEC filings.
$13.7MFY2025 · since FY2020: $2.5M → $13.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.7M | +37.1% |
| FY2024 | $10.0M | — |
| FY2020 | $2.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More DSGN financial trends
DSGN RevenueDSGN Net incomeDSGN Net marginDSGN Gross profitDSGN Gross marginDSGN Operating incomeDSGN Operating marginDSGN Operating cash flowDSGN Free cash flowDSGN Capital expendituresDSGN Return on equityDSGN Stock buybacksDSGN Dividends paidDSGN Total assetsDSGN Shareholders’ equityDSGN overview →